Enterprising achievements accordion
A $15 million initiative was launched to accelerate research commercialisation at Monash.
In partnership with Breakthrough Victoria and providing up to $1 million per spinout, the Pre-Seed Fund also provides mentoring and commercialisation expertise to strengthen pathways from discovery to market.
The Monash Velos Accelerator launched in 2025, a purpose-built $17.5 million translational facility supported by the Victorian Government. Velos is dedicated to accelerating the translation and commercialisation of clinical research, health technologies, new models of care, drug discovery and biomedical engineering.
Our spinout RAGE Biotech secured $29 million in Series A funding, propelling its RNA-based therapeutic platform toward first-in-human clinical trials.